208116-26-1

KAFDITYVRLKF Chemical Structure
208116-26-1

Chemical Structure

KAFDITYVRLKF

  • CAS No.: 208116-26-1
  • Formula:C73H113N17O17
  • Molecular Weight:1500.81

IUPAC Name: (2S,5S,8S,11S,14S,17S,20S,23S,26S)-5-(4-aminobutyl)-2-benzyl-23-((S)-sec-butyl)-26-((S)-2-((S)-2-((S)-2,6-diaminohexanamido)propanamido)-3-phenylpropanamido)-11-(3-guanidinopropyl)-17-(4-hydroxybenzyl)-20-((R)-1-hydroxyethyl)-8-isobutyl-14-isopropyl-4,7,10,13,16,19,22,25-octaoxo-3,6,9,12,15,18,21,24-octaazaoctacosanedioic acid

InChIKey: KBCXTQVDKPAYQJ-KHTXFUALSA-N

SMILES: [C@H](CC1=CC=C(O)C=C1)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC2=CC=CC=C2)C(O)=O)=O)CCCCN)=O)CC(C)C)=O)CCCNC(=N)N)=O)C(C)C)=O)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC3=CC=CC=C3)NC([C@@H](NC([C@H](CCCCN)N)=O)C)=O)=O)CC(O)=O)=O)[C@H](CC)C)=O)[C@@H](C)O)=O

Biological Activity: KAFDITYVRLKF is a selective, competitive integrin αvβ3 binder. KAFDITYVRLKF induces the production of MMP-9. KAFDITYVRLKF blocks monocyte migration, promotes melanoma cell migration, protects neurons, and improves motor and cognitive functions. KAFDITYVRLKF can be used in research related to melanoma and Parkinson's disease[1][2].

Cat. No. Nom du produit Pureté Description Pricing
HY-P11780
KAFDITYVRLKF KAFDITYVRLKF is a selective, competitive integrin αvβ3 binder. KAFDITYVRLKF induces the production of MMP-9. KAFDITYVRLKF blocks monocyte migration, promotes melanoma cell migration, protects neurons, and improves motor and cognitive functions. KAFDITYVRLKF can be used in research related to melanoma and Parkinson's disease.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References